Earnings History Data for X4 Pharmaceuticals, Inc. (XFOR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases. The company's product candidates include X4P-001, X4P-002 and X4P-003 which are in clinical stage. X4 Pharmaceuticals Inc., formerly known as Arsanis, Inc., is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21-03-2024 | PM | XFOR | X4 Pharmaceuticals, Inc. | 154.46 | -0.10 | -0.15 | -0.29 | X4 Pharmaceuticals GAAP EPS of -$0.10 beats by $0.05 [3/21/2024 6:08 AM] |
1.31 | 0.29 (28.43%) |
1.05 | 0.03 (2.94%) |
0.57 - 2.58 | 12,150,829 | 2,180,000 | 687,175 | ||
| 09-11-2023 | PM | XFOR | X4 Pharmaceuticals, Inc. | 133.53 | -0.01 | -0.15 | -0.26 | X4 Pharmaceuticals GAAP EPS of -$0.01 beats by $0.14 [11/9/2023 6:06 AM] |
0.79 | 0.05 (6.68%) |
0.77 | 0.03 (3.97%) |
0.65 - 2.58 | 2,451,506 | 2,770,000 | 224,359 | ||
| 10-08-2023 | PM | XFOR | X4 Pharmaceuticals, Inc. | 206.53 | -0.33 | -0.17 | -0.60 | X4 Pharmaceuticals GAAP EPS of -$0.33 misses by $0.16 [8/10/2023 6:08 AM] |
1.03 | -0.60 (-36.89%) |
1.35 | -0.29 (-17.68%) |
0.65 - 2.58 | 17,678,232 | 1,830,000 | 552,004 | ||
| 04-05-2023 | PM | 6:05 AM ET (May 4) |
XFOR | X4 Pharmaceuticals, Inc. | 175.98 | -0.16 | -0.20 | -0.72 | X4 Pharmaceuticals GAAP EPS of -$0.16 beats by $0.05 [5/4/2023 6:15 AM] |
1.54 | 0.06 (4.39%) |
1.52 | 0.04 (2.70%) |
0.65 - 2.41 | 4,306,421 | 2,660,000 | 87,506 | |
| 21-03-2023 | PM | 6:05 AM ET (Mar 21) |
XFOR | X4 Pharmaceuticals, Inc. | 114.86 | -0.29 | -0.23 | -1.24 | X4 Pharmaceuticals GAAP EPS of -$0.29 misses by $0.05 [3/21/2023 6:07 AM] |
0.8801 | -0.01 (-0.76%) |
0.87 | -0.02 (-1.89%) |
0.65 - 2.41 | 1,245,692 | 1,050,000 | 315,677 | |
| 03-11-2022 | PM | 7:05 AM ET (Nov 3) |
XFOR | X4 Pharmaceuticals, Inc. | 58.26 | -0.26 | -0.31 | -0.76 | X4 Pharmaceuticals GAAP EPS of -$0.26 beats by $0.04 [11/3/2022 6:08 AM] |
1.90 | -0.06 (-3.32%) |
1.85 | -0.11 (-5.61%) |
0.86 - 6.18 | 948,684 | 460,000 | 49,246 | |
| 04-08-2022 | PM | 6:05 AM ET (Aug 4) |
XFOR | X4 Pharmaceuticals, Inc. | 36.68 | -0.60 | -0.65 | -0.74 | X4 Pharmaceuticals GAAP EPS of -$0.60 beats by $0.04 [8/4/2022 7:17 AM] |
1.26 | -0.03 (-2.33%) |
1.31 | 0.02 (1.55%) |
0.86 - 6.21 | 128,359 | 270,000 | 534 | |
| 12-05-2022 | PM | 6:05 AM ET (May 12) |
XFOR | X4 Pharmaceuticals, Inc. | 35.76 | -0.72 | -0.62 | -1.30 | X4 Pharmaceuticals GAAP EPS of -$0.72 misses by $0.11 [5/12/2022 6:06 AM] |
1.04 | -0.01 (-0.95%) |
1.20 | 0.15 (14.29%) |
1.00 - 9.90 | 161,680 | 160,000 | 201 | |
| 17-03-2022 | PM | 9:00 AM ET (Mar 17) |
XFOR | X4 Pharmaceuticals, Inc. | 58.59 | -1.24 | -0.68 | -0.91 | X4 Pharmaceuticals GAAP EPS of -$1.24 misses by $0.56 [3/17/2022 6:10 AM] |
1.78 | -0.20 (-10.10%) |
2.03 | 0.05 (2.53%) |
1.31 - 10.61 | 621,223 | 477,216 | 12,729 | |
| 04-11-2021 | PM | 8:00 AM ET (Nov 4) |
XFOR | X4 Pharmaceuticals, Inc. | 129.28 | -0.76 | -0.72 | -0.87 | X4 Pharmaceuticals EPS misses by $0.04 [11/4/2021 9:17 AM] |
5.15 | -0.45 (-8.04%) |
5.11 | -0.04 (-0.78%) |
4.20 - 10.70 | 608,901 | 230,000 | 270 | |
| 03-08-2021 | PM | 8:00 AM ET (Aug 3) |
XFOR | X4 Pharmaceuticals, Inc. | 142.41 | -0.74 | -0.73 | -0.76 | X4 Pharmaceuticals EPS in-line [8/3/2021 8:19 AM] |
5.66 | -0.27 (-4.55%) |
6.30 | 0.37 (6.24%) |
5.21 - 10.70 | 117,674 | 110,000 | 290 | |
| 06-05-2021 | PM | 8:00 AM ET (May 6) |
XFOR | X4 Pharmaceuticals, Inc. | 145.33 | -1.30 | -0.84 | -0.56 | X4 Pharmaceuticals EPS misses by $0.44 [5/6/2021 8:16 AM] |
8.12 | 0.12 (1.50%) |
8.00 | 0.0 (0.00%) |
5.38 - 11.11 | 91,373 | 90,000 | 300 | |
| 04-03-2021 | PM | 8:00 AM ET (Mar 4) |
XFOR | X4 Pharmaceuticals, Inc. | 158.79 | -0.91 | -0.87 | -0.66 | X4 Pharmaceuticals EPS misses by $0.03 [3/4/2021 8:04 AM] |
9.24 | -0.50 (-5.13%) |
9.74 | 0.0 (0.00%) |
5.38 - 11.11 | 88,399 | 134,568 | 388 | |
| 05-11-2020 | PM | 8:00 AM ET (Nov 5) |
XFOR | X4 Pharmaceuticals, Inc. | 101.95 | -0.87 | -0.74 | -0.95 | X4 Pharmaceuticals EPS misses by $0.12 [11/5/2020 8:09 AM] |
6.01 | -0.43 (-6.68%) |
6.47 | 0.03 (0.47%) |
5.38 - 15.00 | 129,850 | 68,803 | 300 | |
|
|
||||||||||||||||||
| 30-07-2020 | PM | 7:30 AM ET (Jul 30) |
XFOR | X4 Pharmaceuticals, Inc. | 133.43 | -0.76 | -0.70 | -1.02 | X4 Pharmaceuticals EPS misses by $0.04 [7/30/2020 8:03 AM] |
7.78 | -0.23 (-2.87%) |
0.0 | 0.0 (0.00%) |
5.84 - 15.95 | 76,063 | 85,456 | 0 | |
|
|
||||||||||||||||||